Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

By T. Walsh, E. Anaissie, D. Denning, R. Herbrecht, D. Kontoyiannis, K. Marr, V. Morrison, B. Segal, W. Steinbach, D. Stevens and 3 more. Clinical Infectious Diseases, 2008

2,622 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Small Animals

View Paper: https://www.semanticscholar.org/paper/b66f26d6a23c4779fd8dbd261e5c5cfa7595137d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Pfaller
2. D. Diekema
3. D. Kontoyiannis
4. J. Guinea

In Infectious Diseases

1. M. Pfaller
2. D. Diekema
3. D. Kontoyiannis
4. Henry F. Chambers
5. J. Fishman
6. J. Guinea

In Small Animals

1. M. Pfaller
2. D. Diekema
3. D. Kontoyiannis

Citations in the corpus

• 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. (2015, neutral): “The management of patients with fungal NVO is addressed in the referenced IDSA guidelines [62 – 66].”
• Epidemiology of Invasive Mycoses in North America (2010, background): “Specific antifungal therapy for IA often involves the administration of amphotericin B or one of its lipidbased formulations (Walsh et al. 2008).”
• Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. (2014, background): “” Rather, recommendations for these infections are extrapolated from broad group guidelines that include references to SSTIs and have been developed by professional organizations including IDSA, the National Comprehensive Cancer Network (NCCN), American Society of Blood and Marrow Transplantation, t”
• Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. (2016, methodology): “These guidelines replace the practice guidelines for Aspergillus published in 2008 [1] and incorporate new clinical evidence in the recommendations.”